• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Excitonic channels from bio-inspired templated supramolecular assembly of J-aggregate nanowires?
  Daniel Messmer,Stefan Salentinig,Jakob Heier Nanoscale, 2019,11, 6929-6938

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Aminobenzoic acids and derivatives

Introduction to 2-Amino-4,6-bis(trifluoromethyl)benzoic acid (CAS No. 1379686-14-2) and Its Emerging Applications in Chemical Biology

2-Amino-4,6-bis(trifluoromethyl)benzoic acid, identified by the CAS number 1379686-14-2, is a fluorinated aromatic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural and functional properties. The presence of multiple trifluoromethyl groups enhances its lipophilicity and metabolic stability, making it a valuable scaffold for drug design and development. This compound belongs to the benzoic acid family, characterized by a benzene ring substituted with an amino group and two trifluoromethyl groups at the 4th and 6th positions, which contribute to its distinct chemical behavior.

The trifluoromethyl (–CF?) group is a key structural feature that imparts remarkable electronic and steric effects, influencing both the reactivity and biological activity of the molecule. In pharmaceutical applications, such modifications are strategically employed to improve binding affinity, reduce metabolic degradation, and enhance target specificity. The benzoic acid core is well-documented for its role in various biological pathways, including inflammation modulation, enzyme inhibition, and antioxidant properties. The combination of these elements in 2-Amino-4,6-bis(trifluoromethyl)benzoic acid makes it a promising candidate for further exploration in medicinal chemistry.

Recent advancements in computational chemistry and high-throughput screening have facilitated the rapid identification of novel bioactive compounds. The structural motif of 2-Amino-4,6-bis(trifluoromethyl)benzoic acid has been leveraged in virtual screening campaigns to identify potential inhibitors of enzyme targets associated with metabolic disorders and infectious diseases. For instance, studies have highlighted its potential as a scaffold for developing kinase inhibitors, where the fluorinated aromatic ring interacts favorably with the hinge regions of protein targets. This has opened up avenues for designing next-generation therapeutics with improved pharmacokinetic profiles.

In addition to its applications in drug discovery, 2-Amino-4,6-bis(trifluoromethyl)benzoic acid has found utility in material science and agrochemical research. The electron-withdrawing nature of the trifluoromethyl groups enhances the compound's ability to participate in various organic reactions, such as cross-coupling processes and palladium-catalyzed transformations. These reactions are pivotal in synthesizing complex molecules used in advanced materials and crop protection agents. The versatility of this compound underscores its importance beyond pharmaceuticals.

One of the most compelling aspects of 2-Amino-4,6-bis(trifluoromethyl)benzoic acid is its role in modulating biological pathways associated with inflammation and oxidative stress. Preclinical studies have demonstrated that derivatives of this compound exhibit anti-inflammatory effects by inhibiting key pro-inflammatory cytokines and enzymes. The fluorine atoms contribute to increased binding affinity to biological targets, thereby enhancing therapeutic efficacy. Moreover, the benzoic acid moiety is known to possess antioxidant properties, which could synergize with anti-inflammatory actions to provide multifaceted therapeutic benefits.

The synthesis of 2-Amino-4,6-bis(trifluoromethyl)benzoic acid involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, including flow chemistry and catalytic processes, have been employed to optimize production scalability. These techniques not only improve efficiency but also minimize waste generation, aligning with green chemistry principles. As demand for fluorinated compounds grows due to their enhanced bioactivity, efficient synthetic routes will be crucial for meeting industrial needs.

Future research directions for 2-Amino-4,6-bis(trifluoromethyl)benzoic acid include exploring its potential as a lead compound for treating neurodegenerative diseases. Preliminary data suggest that fluorinated benzoic acids may interact with amyloid-beta plaques associated with Alzheimer's disease by modulating cholinergic pathways. Further investigation into its mechanism of action could pave the way for novel therapeutic strategies targeting neuroinflammation and cognitive decline. Collaborative efforts between academic institutions and pharmaceutical companies are essential to translate these findings into clinical applications.

The impact of trifluoromethylation on medicinal chemistry continues to evolve with each new discovery. Compounds like 2-Amino-4,6-bis(trifluoromethyl)benzoic acid exemplify how strategic functionalization can unlock novel pharmacological properties. As computational tools become more sophisticated, virtual screening approaches will increasingly rely on such scaffolds to identify drug candidates with optimized physicochemical properties. This synergy between experimental synthesis and computational modeling accelerates the drug discovery pipeline significantly.

In conclusion,2-Amino-4,6-bis(trifluoromethyl)benzoic acid (CAS No. 1379686-14-2) represents a fascinating example of how structural modifications can enhance biological activity and therapeutic potential. Its unique combination of a benzoic acid core with multiple trifluoromethyl groups makes it a versatile tool for drug design across multiple therapeutic areas. As research progresses，this compound will continue to play a pivotal role in advancing our understanding of disease mechanisms and developing innovative treatments.

• 393-06-6(4-Amino-2-(trifluoromethyl)benzoic Acid)
• 402-13-1(2-Amino-4-(trifluoromethyl)benzoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)